| Inborn metabolic disorders |
| ❖ Criggler-Najjar syndrome type 1 (66,67) |
| ❖ Urea cycle defects (67-71) |
| ⬥ Ornithine transcarbamylase |
| ⬥ Carbamoyl phosphate synthetase type 1 deficiency |
| ⬥ Citrullinemia |
| ❖ Argininosuccinatelyase deficiency |
| ❖ Glycogen storage disease type I (67,72-75) |
| ⬥ Type Ia |
| ⬥ Type Ib |
| ❖ Refsum disease (76) |
| ❖ Phenylketonuria (64,75) |
| ❖ Tyrosinemia type 1 (67) |
| ❖ Factor VII deficiency (77,78) |
| ❖ Primary hyperoxaluria (79) |
| ❖ Familial hypercholesterolaemia (80,81) |
| ❖ Progressive familial intrahepatic cholestasis (78,82) |
| Other liver diseases |
| ❖ Patients with indication of LT (83-89) |
| ⬥ Acute liver failure |
| ⬥ Acute on chronic liver failure |
| ⬥ Non-alcoholic steatohepatitis |
| ❖ Patients with no indication of LT (90-92) |
| ⬥ Patients with postoperative liver failure after partial hepatic resection |
| ⬥ Patients with chronic decompensation of an end-stage liver disease |
| ⬥ Other patients with no indication of LT (i.e., advanced age, alcoholism) |
